Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Soufflé Therapeutics, Inc. has closed an oversubscribed $135 million Series B financing led by Juvia Group to advance its lead clinical programs and continued pipeline progress.

PRIVATEOct 13, 2026

Amount Raised

$135 Million

Round Type

Series B

BostonBiotechnologyHealth CareTherapeutics

Investors

Balyasny Asset ManagementFidelity Management & Research CompanyBB BiotechTCG Crossover ManagementJuvia Group

Description

Soufflé Therapeutics, Inc. announced the close of an oversubscribed $135 million Series B financing. The funding will support the advancement of its lead clinical programs and continued progress on its pipeline. The round saw participation from several leading institutional investors

Company Information

Company

Soufflé Therapeutics

Location

Boston, Massachusetts, United States

About

Soufflé Therapeutics is a biotech company focused on creating siRNA medicines that are targeted and cell-specific. Co-founded by renowned scientist Robert Langer, the firm aims to develop innovative therapies for various diseases with a bold vision for precision medicine. The company has secured significant funding and partnerships with major pharmaceutical companies. Plans are in motion to enter clinical trials by 2026.

Fundz sees it the moment Soufflé Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Soufflé Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Soufflé Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.